Education Grants for Researchers

National Institutes of Health · Up to $200K

NIH (NCI) R21 funding for secondary analysis and integration of existing datasets to study cancer risk and related outcomes; clinical trials are not allowed under this notice. Intended for research institutions and investigators, including minority-serving and tribal colleges. The listed maximum is about $200,000. This is institution-based research funding using existing data, not suited to individuals or general nonprofits.

National Institutes of Health · Amount varies

This NIH R01 grant funds research applications studying the ethical, legal, and social implications of human genetics and genomics, using empirical, conceptual, legal, or normative methods. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP); those without one won't be reviewed. It's aimed at eligible U.S. and territorial research institutions, and the deadline is November 18, 2026.

National Institutes of Health · Amount varies

This NIH R21 grant funds exploratory and developmental research into the ethical, legal, and social implications of human genetics and genomics, particularly studies examining new or emerging genomic technologies. It's open to eligible U.S. and territorial research institutions using empirical, conceptual, legal, or normative methods. The deadline is November 18, 2026.

National Institutes of Health · Amount varies

NIH mechanism allowing existing award recipients to apply for revision (supplemental) funding to expand a current NIH grant or cooperative agreement, only in response to a specific Notice of Special Interest. Restricted to organizations that already hold an active NIH single-project award. No award amount is specified. Because applicants must already be NIH grantees and respond to a matching NOSI, eligibility is narrow and not open to new applicants.

National Institutes of Health · Amount varies

This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, for research that does not involve leading an independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, with a required independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R50 award provides salary support for established Research Software Engineers who build and disseminate biomedical software, tools, and algorithms. Eligible applicants include universities and research institutions; foreign (non-U.S.) organizations are not eligible to apply. It is tied to an existing research environment and specialized staff, so it suits research institutions rather than general nonprofits or individuals applying on their own. No specific award amount is stated.

National Institutes of Health · Up to $375K

This NIH R15 (AREA) award supports small-scale research at undergraduate-focused institutions that receive limited NIH funding, with a required clinical trial. Eligibility is restricted to institutions that award baccalaureate science degrees and have received no more than $6 million/year of NIH support in 4 of the last 7 years; foreign organizations are not eligible to apply. The maximum award is about $375,000. This is narrowly targeted at less-research-intensive degree-granting institutions.

National Institutes of Health · Amount varies

This NIH R01 funds larger-scale research testing and disseminating interventions to improve health in Native American populations, following the same research focus as its companion R34 announcement. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with foreign entities restricted. No award amount is specified.

National Institutes of Health · Amount varies

This NIH R21 funds development of novel theory and methods for understanding the genetic architecture of complex human traits, using interdisciplinary approaches, simulations, and existing large-scale datasets; no clinical trial is allowed. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It is aimed at research teams with methodological expertise. No specific award amount is stated.

National Institutes of Health · Up to $250K

This NIH/National Library of Medicine R01 funds development of informatics and data science approaches that give individuals actionable insights into their own health; a clinical trial is optional. Eligible applicants include universities, research institutions, and tribal and community organizations, and foreign organizations are listed among eligible applicants. The maximum award is about $250,000. It requires informatics research capacity.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute R01 supports investigator-initiated clinical trials in cancer prevention and control, such as early detection, screening, and survivorship research. Typical applicants are universities, research institutions, hospitals, tribal organizations, and government and community organizations; foreign organizations are listed among eligible applicants here. A qualifying clinical trial is required, so it is geared toward established research teams. No specific award amount is stated.

National Institutes of Health · Up to $500K

This NIH/National Cancer Institute R01 funds investigator-initiated early-phase (Phase 0, I, II) clinical trials for cancer diagnosis and treatment; a clinical trial is required. Eligible applicants include universities, research institutions, hospitals, tribal and community organizations, and foreign organizations. The maximum award is just under $500,000. It is geared toward established clinical research teams.

National Institutes of Health · Amount varies

This NIH R01 funds preclinical and patient-based research into how incretin mimetics (such as GLP-1 agents) affect cancer risk. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations; a clinical trial is optional. It requires established research capacity in this area. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R21 funds preclinical and patient-based research into how incretin mimetics (such as GLP-1 agents) affect cancer risk; no clinical trial is allowed. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It requires research capacity in this area. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R34 funds early-stage research and pilot studies testing interventions to improve health outcomes in Native American communities, including etiologic research and culturally-informed treatment studies. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with some restrictions on foreign entities. No award amount is specified; a clinical trial component is optional.

National Institutes of Health · Amount varies

This NIH R01 funds research testing interventions that expand cancer screening and preventive-service uptake in populations facing health disparities, ideally involving community partners. Eligible applicants include universities, minority- and tribal-serving institutions, and community-based organizations, but non-U.S. organizations and their foreign components are excluded. No award amount is specified; this is a research grant requiring a clinical trial component.

National Institutes of Health · Up to $500K

This NIH/National Cancer Institute R01 funds academic-industrial partnerships to translate and validate in vivo imaging, data science, or spectroscopic technologies into tools for cancer and other diseases; a clinical trial is optional. Eligible applicants include universities, research institutions, and tribal and community organizations, and foreign organizations are listed among eligible applicants. The award maximum is about $500,000, and the model assumes an academic-industry collaboration. It is aimed at research teams.

National Institutes of Health · Amount varies

This NIH R01 funds research into population-level approaches for reducing alcohol-related cancer risk, including policy analysis, social-norms research, and intervention testing. It's open to a wide range of research-capable organizations — universities, minority- and tribal-serving institutions, faith-based and community organizations, and federal agencies — though foreign entities face restrictions. No award amount is specified; this is a research grant, not general operating support.

National Institutes of Health · Up to $350K

This NIH HEAL Initiative R61/R33 funds early translational drug-discovery research toward non-addictive pain therapeutics, including assay development, screening, and initial characterization of candidate agents; no clinical trial is allowed. Eligible applicants include universities, research institutions, and tribal and community organizations, but foreign organizations are not eligible to apply. The maximum award is about $350,000. It requires drug-discovery research capacity.